The Impact of Erythropoietin on Short and Long-term Kidney-Related Outcomes in Extremely Low Gestational Age Neonates. Results of a Multi-center Double-Blind Placebo-Controlled Randomized Clinical Trial

OBJECTIVE: To evaluate whether extremely low gestational age neonates (ELGANs) randomized to erythropoietin have better or worse kidney-related outcomes during hospitalization and at 22–26 months corrected gestational age (cGA) compared with those randomized to placebo. STUDY DESIGN: We performed an...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Pediatr
Main Authors: Askenazi, David J., Heagerty, Patrick J., Schmicker, Robert H., Brophy, Patrick, Juul, Sandra E., Goldstein, Stuart L., Hingorani, Sangeeta
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8093092/
https://ncbi.nlm.nih.gov/pubmed/33484699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2021.01.031
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares